News

Discover the latest news and developments in AI and machine learning happening in the image-guided therapy (IGT) sector in Canada.

Sonic Incytes is making liver screening more accessible 

Sonic Incytes is making liver screening more accessible 

Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur™, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).

Network News

IGT Lecture Series

Regulating AI in Image-Guided Therapy

Follow INOVAIT on Social Media

The Network in the Press

Logo for Canadian Healthcare Technology Magazine
The logo for the Financial post
The logo for Yahoo Finance
The logo for betakit
The logo for The Record